29.8% growth, margin recovery delayed by raw material volatility
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Prior guidance margin recovery Q2–Q3 missed; management citing cost negotiations ongoing, expecting resolution H2. Order book claims corroborated but execution timeline 2–4 years.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
PPAP delivered strong 29.8% revenue growth and secured ₹429 Cr lifetime order book, but gross margin compression (45.6% → 39.8%) and weak NPM (1.4%) reveal cost pass-through lags remain unresolved. Management deferred margin recovery guidance from Q2–Q3 to H2 FY27, citing raw material volatility. Order visibility is genuine but profitability recovery is contingent on price revisions yet to settle.
₹177.8 Cr
Revenue · +29.8% YoY₹2.5 Cr
Reported PAT · +5525.2% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Record quarterly revenue supported by strong customer demand
MET₹177.8 Cr, +29.8% YoY; highest ever Q2 sales confirmed
Margin recovery by Q2–Q3 FY27 if cost negotiations settle
OVERSTATEDGross margin 39.8% Q2 vs 45.6% prior year; NPM 1.4% vs recovery target. OPM 8.8% vs 12–13% sustainable target
Capacity utilization moving toward 80–82% target
MET78% in Q2 vs 68% Q2 prior year; on track but not yet at target
Lifetime order book ₹429 Cr in H1, with ₹300 Cr added in Q2 alone
METManagement stated ₹300 Cr wins Q2, ₹429 Cr cumulative H1; execution 2–4 year window
Aftermarket to reach 10% of group revenue over coming years
METCurrently 5% of group sales; ₹24% YoY growth in Q2 affirms momentum but multi-year target
EV order book growth reflects strong EV adoption momentum
OVERSTATEDEV orders ₹156.5 Cr H1 vs ₹127 Cr H1 prior year (~23% growth, not 6x); press release phrasing '6x growth' likely refers to new orders secured Q2 alone vs comparator
Earnings quality
What changed since the last call
Margin recovery timeline pushed to H2
DowngradeQ1 call: recovery by Q2–Q3 if cost negotiations settle. Q2 call: recovery deferred to H2 FY27. Gross margin compressed 680 bps; pass-through still pending with ~6-month lag forecast.
Order book strength confirmed
Upgrade₹429 Cr lifetime wins H1 (₹300 Cr Q2 alone) vs prior expectations; EV orders embedded. Provides 2–4 year revenue visibility.
Capacity expansion pace accelerated
UpgradeChennai plant targeting Q3 operational (earlier than Q3 'based on demand' commentary Q1 call); utilization 78% vs 68% prior year Q2.
Aftermarket trajectory reaffirmed but unchanged
Neutral5% of revenue, +24% YoY growth; 10% target remains multi-year (Q3–Q4 target now under review). Management confirmed expansion to 154 distributors ongoing.
The Q&A
Analysts pressed hard on margin recovery and cost pass-through timing. Sachin Jain acknowledged Q2–Q3 guidance had not materialized and committed 'definitely' to Q1 recovery but hedged with caveats: Western disturbance volatility, 6-month lag in realizing price increases. Management held firm on operational efficiency gains offsetting some cost pressure but could not quantify EBITDA uplift—tone was cautious but constructive.
Order book execution — Mihir, MB Securities
AnsweredOrders executed over 2–4 year window; H2 FY27 ramp-up expected from new programs starting, particularly Maruti and Tata. 10% of top line from new orders (₹300 Cr Q2 alone).
Margin recovery timing — Mihir, MB Securities
Partial68% of cost increases already recovered from customers; balance 32% in process, expected to settle in H2 (6-month lag from negotiation to realization).
EBITDA guidance forward — Payal Shah, Billion Securities
DodgedDifficult to quantify due to Western disturbance, raw material volatility. Confident there will be significant improvement due to demand lift and price recovery.
Industrial Products growth — Vanshi Shah, EVNA Financial Advisory
AnsweredIndustrial Products 64% revenue growth Q2 (₹2.8 Cr). Exporting sealing systems to US, Africa. Non-automotive ~30% of tooling revenue. Building export and diversification play; aim to scale further.
Battery business losses — Vanshi Shah, EVNA Financial Advisory
AnsweredEBITDA loss reduced from ₹1.2 Cr to ₹30 lakh in H1. Hopeful for zero EBITDA in Q3; execution tied to customer claims and cost recoveries.
Aftermarket scaling — Jigar Shah, Elevate Research
AnsweredCurrently 5% of revenue; 154 distributors in place. Plans 2 additional regional warehouses by Q4 FY27 (North, South, West, then East). Online expansion via Amazon, Flipkart ongoing. 10% target remains multi-year goal.
Guidance
No new FY27 quantified revenue target issued
MediumOrder book ₹429 Cr provides ~2–4 year revenue visibility; H2 ramp-up expected from new programs, but no explicit FY27 target stated.
Sustainable OPM 12–13% for OEM business (from Q1 call guidance)
MediumQ2 OPM 8.8%; margin recovery deferred to H2 FY27 pending cost pass-through. Gross margin compression (39.8% vs 45.6%) unresolved.
Margin recovery to begin H2 FY27 (cost pass-through expected settled)
Low68% of cost increases recovered from customers; 32% pending resolution within 6 months. Contingent on raw material price stabilization.
Chennai plant operational by Q3 FY27; further expansion based on order book
MediumNew plant investments made; expected fully operational Q3. Capacity expansion to follow based on demand and customer allocations.
Risks the call surfaced
Margin recovery delay
HighGross margin compressed 680 bps Q2 YoY; pass-through mechanism 68% complete but 32% pending with 6-month lag. If raw material prices spike again, recovery window narrows.
Order book execution risk
Medium₹429 Cr lifetime orders over 2–4 year window; execution contingent on ramp-up timelines of new vehicle platforms and customer demand. Any OEM delay impacts revenue.
EV adoption timing
MediumEV orders ₹156.5 Cr H1 but EV penetration in Indian market still sub-5%; customer volume ramp dependent on OEM launch schedules and pricing competitiveness.
Aftermarket scale-up
LowAftermarket currently 5% of revenue; 10% target multi-year. Requires sustained distribution expansion, inventory management, and brand awareness—capital and execution intensive.
Raw material volatility
MediumWestern disturbance cited as ongoing headwind; oil, steel, aluminium prices volatile. Management hedging tools and cost management in place but exposure remains.
Management
Score 6/10. Largely transparent on challenges. CFO Sachin Jain candid on margin pressure and pass-through lags; acknowledged prior Q2–Q3 recovery guidance not on track. But avoided quantifying EBITDA improvement forward, citing volatility—reasonable caution but limits visibility. Strong revenue growth (29.8% YoY) and order book (₹429 Cr) demonstrate execution on sales/BD. Margin recovery targets missed (prior guidance Q2–Q3, now H2). Capacity targets on track (78% toward 82%). Aftermarket scaling underway but multi-year.
1 · Q3 FY27 (Dec 2026)
Chennai plant operational; capacity +10–15%
2 · Q3 FY27
Meraki tooling business spinoff expected (reorganization)
3 · H2 FY27 (Jan–Mar 2027)
Cost pass-through realization; margin recovery to begin
Order visibility is genuine but profitability recovery is contingent on price revisions yet to settle.
Order book is real, but margin recovery is not yet proven
PPAP reported ₹177.8 Cr revenue (+29.8% YoY), but gross margin compressed 680 basis points and net profit jumped on a low prior-year base. The order book of ₹429 Cr (lifetime) is genuine—but profitability recovery now hinges on cost pass-through in H2, missing the prior Q2–Q3 guidance.
The tension: headline profit vs. operational reality
₹2.5 Cr
+5525% YoY
₹0.05 Cr loss
Leverage effect, not margin
1.4%
vs 12–13% target
39.8%
was 45.6%; −680 bps
The +5525% PAT growth looks like a blowout until you see the denominator: ₹0.05 Cr loss in the prior quarter. PPAP's profitability recovery is a leverage effect—higher revenue (₹177.8 Cr, +29.8% YoY) spreading fixed costs over a larger base—not operational margin expansion. The real story is the 680-basis-point compression in gross margin (45.6% down to 39.8%), driven by raw material volatility and unfavorable product mix, and the company's unfulfilled commitment to recover margin by Q2–Q3 FY27.
Management's claims vs. what holds up
"Record quarterly revenue supported by strong customer demand"
₹177.8 Cr, +29.8% YoY; highest ever Q2 sales
"Margin recovery by Q2–Q3 FY27 if cost negotiations settle"
Delivered: gross margin compressed; OPM 8.8% vs 12–13% target. Recovery deferred to H2.
"Capacity utilization moving toward 80–82% target"
78% Q2 vs 68% prior year Q2; on track, not yet at target.
"Lifetime order book ₹429 Cr, with ₹300 Cr added Q2 alone"
Confirmed; 2–4 year execution window. EV orders ₹156.5 Cr (36% of total).
"EV order book growth reflects strong EV adoption momentum"
EV orders ₹156.5 Cr H1 vs ₹127 Cr prior (~23% growth, not "6x"). Phrasing likely refers to Q2 new wins alone.
The margin guidance miss is the headline failure: management had committed to margin recovery by Q2–Q3 contingent on cost negotiations, but Q2 delivered the opposite (−680 bps compression). CFO Sachin Jain acknowledged this in the Q&A, stating that 68% of cost increases have been recovered from customers and the remaining 32% is "in process" with a 6-month lag forecast to realize in H2 FY27. The order book, capacity progress, and revenue growth are all real—but they're offset by a profitability shortfall that now rides on H2 execution.
What changed on this call
Margin recovery
Deferred to H2 FY27; 68% recovered, 32% pending
⬇ Downgrade
By Q2–Q3 if cost negotiations settle
Order book
₹429 Cr lifetime H1; ₹300 Cr Q2 alone; EV ₹156.5 Cr
⬆ Upgrade
Track record of wins
Capacity expansion
Q3 FY27 operational confirmed; 78% utilization (vs 68% prior year)
⬆ Accelerated
Chennai plant Q3 'based on demand'
Aftermarket target
Currently 5%, +24% YoY. 154 distributors in place. Unchanged multi-year aspiration.
→ Neutral
10% of revenue (multi-year)
The key downgrade is the margin timeline: from Q2–Q3 to H2. The key upgrades are the order book (now quantified at ₹429 Cr lifetime vs. prior vague forward commentary) and capacity execution (Chennai Q3 confirmed). Aftermarket is progressing (+24% YoY, 154 distributors), but the 10% revenue target is clearly multi-year, not near-term.
Earnings quality: where the profit sits
Gross margin compression unrecovered
HIGH680 bps compression Q2 vs prior year; driven by raw material cost + product mix (more battery/tooling sales). Pass-through mechanism claimed but 32% still pending with 6-month lag into H2.
PAT recovery on low base, leverage effect
MEDIUMPrior year was ₹0.05 Cr loss; Q2 ₹2.5 Cr profit is a denominator effect, not margin expansion. NPM 1.4% vs sustainable target; shows fixed-cost absorption, not operational margin strength.
EBITDA improvement unquantified forward
MEDIUMCFO Payal Shah asked for H2 EBITDA margin guidance; answer was 'difficult to quantify due to Western disturbance, raw material volatility.' Limits credibility of recovery claim—no specific number to benchmark.
EV order growth phrasing '6x' vague
LOWCall phrasing 'substantial growth' and press release '6x growth' in EV orders misleading. H1 YoY arithmetic is ~23% (₹156.5 Cr vs ₹127 Cr prior year). Likely refers to Q2 new orders alone. Minor clarity issue.
The bull-bear ledger
✓ Order book strength: ₹429 Cr lifetime (2–4 year visibility). Maruti, Tata, JSW, MG Motors, VinFast confirmed. 36% in EV.
✓ Revenue growth outpacing market: +29.8% YoY on 18.2% domestic vehicle sales growth. Volume leverage evident.
✓ Capacity ramp on track: 78% utilization (toward 82% target). Chennai plant Q3 operational. Supports order execution.
✓ EV exposure embedded: ₹156.5 Cr of ₹429 Cr order book; provides long-term optionality as EV adoption accelerates.
✗ Gross margin compression 680 bps unrecovered. Target 12–13% OPM, delivered 8.8% Q2.
✗ Margin recovery guidance missed: Q1 call promised Q2–Q3 recovery. Q2 delivered -680 bps instead. Credibility hit.
✗ Cost pass-through mechanism incomplete: 68% recovered, 32% pending with 6-month lag. If raw material spikes again, recovery window narrows.
✗ PAT recovery on low base: ₹2.5 Cr profit from ₹0.05 Cr loss is leverage, not margin strength. NPM 1.4% vs 12–13% target.
✗ Aftermarket still early-stage: 5% of revenue (target 10%). Capital-intensive distribution expansion; multi-year ramp.
Risks, ranked by how much they should concern a holder
Margin recovery delay or failure
HIGHGross margin compressed 680 bps; pass-through mechanism only 68% complete. If 32% pending recovery stalls or raw material prices spike again, margin recovery window closes. Q1 guidance miss reduces credibility of H2 recovery claim.
Order book execution slippage
MEDIUM₹429 Cr lifetime orders execute over 2–4 years. Any OEM platform delay or volume reduction impacts revenue visibility. Customer concentration risk (Maruti, Tata, JSW) if demand slows.
EV adoption timing mismatch
MEDIUMEV orders ₹156.5 Cr (36% of total) but EV penetration in India still sub-5%. Order conversion contingent on OEM vehicle launch pace and market adoption speed, which is uncertain.
Raw material price volatility persistence
MEDIUMWestern disturbance cited as ongoing headwind. If steel, aluminium, oil prices remain elevated, the 6-month lag in price pass-through means margin pressure persists through H2 and beyond.
Aftermarket scale-up capital intensity
LOWAftermarket at 5% revenue; 10% target multi-year. Requires sustained 20%+ YoY growth for 2–3 years, funded through distribution expansion, warehousing, and brand building. Capital-heavy; execution risk.
How the market is positioned
PPAP trades at ₹252 as of 2026-11-16, sitting above key moving averages (SMA20 ₹226.68, SMA50 ₹235.67, SMA200 ₹234.38) in a bullish trend. RSI at 59 is neutral—no overbought signal. The stock has recovered 43% off its 52-week low (₹176) but remains 65% below its all-time high (₹723.1), indicating significant prior pessimism and partial recovery. Volume is increasing, suggesting growing retail/institutional interest.
Ownership structure is stable but FII trimming is a subtle warning: Promoter holding 64.30% (unchanged), FII 5.66% (down 18 basis points QoQ), DII 0.00% (no activity). The FII reduction, while small, suggests institutional investors are neither accumulating on strength nor building positions ahead of margin recovery—a tepid stance that matches the fundamental "show me" dynamic.
Bulk/block deal activity is clean: July 2026 saw typical arbitrage trades (GM bulk buy/sell around ₹326–₹329) and research-firm positions (NK Securities, Indra Kiran Ventures around ₹235–₹246). No promoter or insider selling near the highs (₹379.5). No red flag on insider conviction.
Market verdict on the print: The stock's post-result behavior (bullish trend above moving averages, increasing volume, but FII slight trim) suggests cautious optimism: the market is acknowledging order book strength and revenue growth, but not giving PPAP the benefit of the doubt on margin recovery until H2 proves it. The 65% drawdown from ATH is still the dominant narrative—this is a stock the market is rebuilding confidence in, not one accelerating to new highs.
What to watch next
1 · Q3 FY27 (Dec 2026): Chennai plant operational + capacity utilization progress
Chennai plant is scheduled to go operational in Q3. Watch for capacity utilization progression toward 80–82% target and first revenue contribution from the new facility. This is the execution proof point for capacity ramp and order conversion.
2 · H2 FY27 (Jan–Mar 2027): Cost pass-through realization
The critical inflection. Management claims 32% of cost increases will settle in H2 with a 6-month lag from negotiation. Watch Q3 gross margin and EBITDA margin for evidence of recovery. This is the make-or-break for the entire margin recovery narrative.
3 · Q4 FY27: Hutchinson partnership first commercial order + aftermarket progress
First commercial order from Hutchinson body sealing tech partnership expected Q4. This is a higher-margin, new technology revenue stream. Also track aftermarket scale: 154 distributors, 2 new regional warehouses planned (North, South, West, East). Progress here would validate the diversification play.
The number to track from here
Gross margin in Q3 FY27. Everything rides on this. If Q3 gross margin recovers even to 42–43% (a move toward the 45.6% target), the cost pass-through narrative is validated and H2 recovery is real. If Q3 margin stays at 39–40%, the 6-month lag claim is suspect and the margin recovery window extends further into FY28. This single line item will determine whether the street's cautious optimism (FII stable, stock above averages, but no new highs) becomes conviction.
PPAP has delivered the order book it promised (₹429 Cr), executed on revenue growth (29.8% YoY), and is on track with capacity expansion (78% toward 82%). But it has also failed its Q2–Q3 margin recovery guidance and delivered operational profit at less than 1/10th of target. This is not a step-change improvement, and it is not a margin-expansion story yet. It is a high-growth, low-profitability transition phase, where execution on cost recovery in H2 FY27 will separate belief from hope. Hold for now, but the credibility bar for the next call is high: show H2 gross margin recovery (toward 43%+), and PPAP moves from "cautiously optimistic" to "upgrade candidate." Fail to recover, and the order book story will be priced as a 2–4 year visibility play, not a near-term profitability recovery.
PPAP Automotive: consolidated turns profitable, revenue +30% YoY, OPM below target
revenue +29.84% · margins expanding
₹177.83 Cr
+29.84% YoY
₹2.47 Cr
1.38%
+1.4pp YoY
₹1.75
PPAP Automotive's consolidated (primary) results for Q2 FY27 show revenue of ₹177.83 Cr, up 29.8% YoY and 13.7% QoQ, with consolidated PAT of ₹2.47 Cr against a near-breakeven loss of ₹0.05 Cr a year ago and ₹0.87 Cr last quarter — a YoY turnaround from loss to profit, even if the prior-year base was only marginally negative. The standalone (parent-only) print is noticeably stronger: PAT of ₹3.49 Cr, up 79% YoY on standalone revenue of ₹165.08 Cr (+24% YoY). The ~₹1 Cr gap between standalone and consolidated PAT is the Group's five subsidiaries, led by Avinya Batteries (lithium-ion packs for two/three-wheelers), which the auditors flag as a combined ₹0.96 Cr net loss for the quarter — readers comparing the two bases should not read the consolidated number as 'wrong', it simply carries the EV-battery drag that standalone does not.
Q2 FY-2027 vs prior quarters
Margins are a mixed signal YoY. Consolidated OPM (EBITDA margin) came in at 8.8%, better than last quarter's 7.9% but below the 9.3% of a year ago — so the sequential recovery management flagged on the last call is only partly showing up, and OPM remains well short of the 12-13% 'sustainable OEM margin' management has cited as its target. NPM improved to 1.4% from 0.6% (QoQ) and from -0.03% (YoY), but that is mechanically the loss-to-profit swing rather than a margin story on its own.
The stock went into the print at ₹218, down 12.1% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
No new FY27 quantitative guidance. Management conditional: margin recovery by Q2-Q3 if cost negotiations settle; capacity targets 80-82% (currently 73%); aftermarket to 10% of revenue; debt-free in 3 years; sustainable OPM 12-13% for OEM business.
— This quarter: missed
On guidance, management gave no new FY27 quantitative guidance last call, only conditional markers: margin recovery by Q2-Q3 'if cost negotiations settle', capacity moving from 73% toward an 80-82% target, aftermarket scaling to 10% of revenue, and a 12-13% sustainable OEM OPM. This quarter's OPM is still below both the year-ago level and the stated target, so that conditional recovery call is, at best, only partially on track rather than met. No management press release or commentary was available with this filing, so there is no company framing to reconcile against the numbers this quarter. We found no published Street consensus for PPAP's Q2 FY27 revenue or PAT — the stock carries thin analyst coverage with no submitted estimates on record — so vsStreet is unknown rather than inferred. Corporate activity this quarter: the Board declared an interim dividend of ₹1.5/share (record date 13-Nov-2026) and approved an ESOP grant of 74,753 options, while the NCLT-ordered amalgamation of Avinya Batteries into the parent (appointed date 1-Apr-2026) continued through creditor and shareholder meetings in August-September 2026.
W1
OPM trajectory toward management's 12-13% sustainable target — only 8.8% this quarter, with the 'Q2-Q3 margin recovery' call conditional on cost negotiations management has not confirmed as settled
W2
Completion of the Avinya Batteries amalgamation (appointed date 1-Apr-2026) — should close the ~₹1 Cr quarterly standalone-consolidated PAT gap once effective
W3
Capacity utilisation against management's 80-82% target, cited as 73% as of the last call
No exceptional items in Q2 FY27 or either comparison quarter (only FY26's full year carried a JV stake-sale gain and a subsidiary impairment); standalone PAT (₹3.49 Cr) and consolidated PAT (₹2.47 Cr) diverge by >3% because 5 subsidiaries, chiefly the EV-battery unit Avinya Batteries now being amalgamated into the parent, posted a combined ₹0.96 Cr net loss this quarter per the auditor's other-matters note.